Department of Aquatic Ecology and Water Quality Management, Wageningen University, Wageningen University and Research Centre, P.O. Box 47, 6700 AA Wageningen, The Netherlands.
Sci Total Environ. 2014 Jan 15;468-469:630-41. doi: 10.1016/j.scitotenv.2013.08.063. Epub 2013 Sep 21.
Aquaculture production constitutes one of the main sources of pollution with veterinary medicines into the environment. About 90% of the global aquaculture production is produced in Asia and the potential environmental risks associated with the use of veterinary medicines in Asian aquaculture have not yet been properly evaluated. In this study we performed a probabilistic risk assessment for eight different aquaculture production scenarios in Asia by combining up-to-date information on the use of veterinary medicines and aquaculture production characteristics. The ERA-AQUA model was used to perform mass balances of veterinary medicinal treatments applied to aquaculture ponds and to characterize risks for primary producers, invertebrates, and fish potentially exposed to chemical residues through aquaculture effluents. The mass balance calculations showed that, on average, about 25% of the applied drug mass to aquaculture ponds is released into the environment, although this percentage varies with the chemical's properties, the mode of application, the cultured species density, and the water exchange rates in the aquaculture pond scenario. In general, the highest potential environmental risks were calculated for parasitic treatments, followed by disinfection and antibiotic treatments. Pangasius catfish production in Vietnam, followed by shrimp production in China, constitute possible hot-spots for environmental pollution due to the intensity of the aquaculture production and considerable discharge of toxic chemical residues into surrounding aquatic ecosystems. A risk-based ranking of compounds is provided for each of the evaluated scenarios, which offers crucial information for conducting further chemical and biological field and laboratory monitoring research. In addition, we discuss general knowledge gaps and research priorities for performing refined risk assessments of aquaculture medicines in the near future.
水产养殖生产是兽医药物向环境中污染的主要来源之一。全球约 90%的水产养殖产量产自亚洲,而亚洲水产养殖中使用兽医药物所带来的潜在环境风险尚未得到充分评估。在本研究中,我们通过结合兽医药物使用和水产养殖生产特征的最新信息,对亚洲的 8 种不同水产养殖生产场景进行了概率风险评估。我们使用 ERA-AQUA 模型对水产养殖池塘中进行的兽医药物处理进行了质量平衡计算,并对通过水产养殖废水可能接触到化学残留物的初级生产者、无脊椎动物和鱼类进行了风险特征描述。质量平衡计算表明,平均而言,大约 25%的施用于水产养殖池塘的药物质量会释放到环境中,尽管这一比例因化学物质的特性、应用方式、养殖物种密度以及水产养殖池塘的水交换率而有所不同。一般来说,寄生虫治疗的潜在环境风险最高,其次是消毒和抗生素治疗。越南的巴沙鱼养殖和中国的对虾养殖,由于水产养殖生产的强度以及大量有毒化学残留物排放到周围水生生态系统中,可能成为环境污染的热点。我们对每个评估场景中的化合物进行了基于风险的排序,这为开展进一步的化学和生物现场及实验室监测研究提供了关键信息。此外,我们还讨论了在不久的将来进行水产养殖药物精细化风险评估的一般知识差距和研究重点。